Cargando…

Navigating the Landscape of Molecular Testing and Targeted Treatment of Non–Small Cell Lung Cancer

Detalles Bibliográficos
Autores principales:	Padda, Sukhmani K., Harvey, R. Donald
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Harborside Press 2016
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5679045/ https://www.ncbi.nlm.nih.gov/pubmed/29152393

Ejemplares similares

Advances in Treatment of Recurrent Small Cell Lung Cancer (SCLC): Insights for Optimizing Patient Outcomes from an Expert Roundtable Discussion
por: Das, Millie, et al.
Publicado: (2021)

A phase 1b study of erlotinib and momelotinib for the treatment of EGFR-mutated, tyrosine kinase inhibitor-naive metastatic non-small cell lung cancer
por: Padda, Sukhmani K., et al.
Publicado: (2021)

The emerging treatment landscape of targeted therapy in non-small-cell lung cancer
por: Yuan, Min, et al.
Publicado: (2019)

Novel Targets, Novel Treatments: The Changing Landscape of Non-Small Cell Lung Cancer
por: de Jong, Dorine, et al.
Publicado: (2023)

The role of induction therapy for thymic malignancies: a narrative review
por: Patel, Deven C., et al.
Publicado: (2020)

Resolution of Crizotinib-Associated Fulminant Hepatitis following Cessation of Treatment
por: Charville, Gregory W., et al.
Publicado: (2018)

Current treatment landscape for oligometastatic non-small cell lung cancer
por: Garde-Noguera, Javier, et al.
Publicado: (2022)

Navigating Diagnostic and Treatment Decisions in Non‐Small Cell Lung Cancer: Expert Commentary on the Multidisciplinary Team Approach
por: Popat, Sanjay, et al.
Publicado: (2020)

The molecular landscape of histone lysine methyltransferases and demethylases in non-small cell lung cancer
por: Li, Jiaping, et al.
Publicado: (2019)

Navigating the organizational landscape
por: Kelly, Lois
Publicado: (2018)

The Purinergic Landscape of Non-Small Cell Lung Cancer
por: Janho dit Hreich, Serena, et al.
Publicado: (2022)

Biomarkers/Molecular Targets, Immunotherapy, and Treatments for Non–Small Cell Lung Cancer
por: Waxman, Elizabeth S., et al.
Publicado: (2016)

Real-world risk of brain metastases in stage III non-small cell lung cancer in the era of PET and MRI staging
por: Alhusaini, Saud, et al.
Publicado: (2023)

Navigating the Interface Between Landscape Genetics and Landscape Genomics
por: Storfer, Andrew, et al.
Publicado: (2018)

Navigating the disease landscape: knowledge representations for contextualizing molecular signatures
por: Saqi, Mansoor, et al.
Publicado: (2018)

Navigating the current landscape of scientific publishing – the Molecular Oncology perspective
por: Ryan, Kevin M.
Publicado: (2022)

RRx-001 followed by platinum plus etoposide in patients with previously treated small-cell lung cancer
por: Morgensztern, Daniel, et al.
Publicado: (2019)

RET Fusion-Positive Non-small Cell Lung Cancer: The Evolving Treatment Landscape
por: Novello, Silvia, et al.
Publicado: (2023)

Tumor immunity landscape in non-small cell lung cancer
por: Yu, Xiaoqing, et al.
Publicado: (2018)

Resectable non-small cell lung cancer: an evolving landscape
por: Loh, Jerold, et al.
Publicado: (2022)

Changing the landscape of non-small cell lung cancer disparities
por: Odera, Joab O., et al.
Publicado: (2021)

The Circular RNA Landscape of Non-Small Cell Lung Cancer Cells
por: Van Der Steen, Nele, et al.
Publicado: (2020)

Thyroid Eye Disease: Navigating the New Treatment Landscape
por: Dosiou, Chrysoula, et al.
Publicado: (2021)

Navigating the landscape of multiplayer games
por: Omidshafiei, Shayegan, et al.
Publicado: (2020)

Autoimmune Disease in Patients With Advanced Thymic Epithelial Tumors
por: Singhal, Surbhi, et al.
Publicado: (2022)

Current Landscape of Non-Small Cell Lung Cancer: Epidemiology, Histological Classification, Targeted Therapies, and Immunotherapy
por: Rodak, Olga, et al.
Publicado: (2021)

Pembrolizumab—the “KEY” to an evolving landscape in treatment of squamous non-small cell lung cancer (NSCLC)
por: Yellala, Amulya, et al.
Publicado: (2020)

Targeted Molecular Treatments in Non-Small Cell Lung Cancer: A Clinical Guide for Oncologists
por: Bui, Kim Tam, et al.
Publicado: (2018)

The spatial transcriptomic landscape of non-small cell lung cancer brain metastasis
por: Zhang, Qi, et al.
Publicado: (2022)

Novel Emerging Molecular Targets in Non-Small Cell Lung Cancer
por: Rebuzzi, Sara Elena, et al.
Publicado: (2021)

The evolving immuno-oncology landscape in advanced lung cancer: first-line treatment of non-small cell lung cancer
por: Low, Jia Li, et al.
Publicado: (2019)

Navigation through the Plasma Membrane Molecular Landscape Shapes Random Organelle Movement
por: Dun, Alison R., et al.
Publicado: (2017)

A landscape of response to drug combinations in non-small cell lung cancer
por: Nair, Nishanth Ulhas, et al.
Publicado: (2023)

Molecularly targeted approaches herald a new era of non-small-cell lung cancer treatment
por: Kaneda, Hiroyasu, et al.
Publicado: (2013)

Non-Small Cell Lung Cancer Treatment with Molecularly Targeted Therapy and Concurrent Radiotherapy—A Review
por: Król, Katarzyna, et al.
Publicado: (2023)

Targeting tumor-associated macrophages for the immunotherapy of glioblastoma: Navigating the clinical and translational landscape
por: Wang, Zide, et al.
Publicado: (2022)

Genomic clustering analysis identifies molecular subtypes of thymic epithelial tumors independent of World Health Organization histologic type
por: Padda, Sukhmani K., et al.
Publicado: (2021)

Immunotherapy for Non-small Cell Lung Cancer: Current Landscape and Future Perspectives
por: Lim, Sun Min, et al.
Publicado: (2020)

Mutational landscape and characteristics of ERBB2 in non‐small cell lung cancer
por: Wei, Xue‐Wu, et al.
Publicado: (2020)

The Emerging Therapeutic Landscape of ALK Inhibitors in Non-Small Cell Lung Cancer
por: Gristina, Valerio, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_mdukoqm616lvnojubhrthfgc1s